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A MODEL TO STUDY THE EFFECTS OF WHOLE LIFE CHRONIC EXPOSURE TO 
ARSENIC OR CADMIUM ON THE DEVELOPMENT OF ADULT METABOLIC 
SYNDROME: INITIAL CHARACTERIZATION OF HEPATIC CHANGES 
 
 





Metabolic syndrome (MetS) is a group of diseases affecting < 30% of adults. 
Although obesity is a major risk for the development of MetS, it does not account for all 
cases, suggesting contribution of other risk factors. We hypothesized that early life 
exposure to arsenic (As) or cadmium (Cd) may represent such a risk. The purpose of 
this study was to characterize a model to discern the effects of early life exposures to Cd 
and As on high fat diet (HFD)-induced MetS. Adult C57BL/6J mice were exposed to 
control or metals containing drinking water. Pregnant dams and offspring were 
continuously exposed to the same toxicants as their parents. At weaning, offspring were 
fed LFD or HFD and sacrificed 10 or 24 weeks later. Metal exposure caused time- and 
sex-dependent alterations in HFD-induced variables of liver damage. The initial results 
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Obesity is a growing epidemic, with more than one third of adults in the United 
States considered to be overweight (1). By the year 2050 the number of obese 
individuals in the United States is expected to double (2). Obesity is a risk factor for a 
spectrum of health conditions including type 2 diabetes, hypertension, non-alcoholic fatty 
liver disease (NAFLD), and cancer (1). A combination of these obesity-induced 
conditions can lead to yet another growing epidemic known as metabolic syndrome.  
Metabolic syndrome is a multifactorial condition that affects over 47 million 
people in the United States (3).  Adults diagnosed with metabolic syndrome are at a five 
times higher risk of mortality (3). As defined by the World Health Organization, metabolic 
syndrome diagnosis requires the manifestation of any of the three following clinical 
conditions: hyperglycemia resulting from insulin resistance, hypertension, central 
obesity, and dyslipoproteinemia as a result of high triglyceride levels or low levels of 
high-density lipoprotein (HDL) (4). Although obesity is a primary risk factor for the 
development of these conditions, not all obese individuals develop metabolic syndrome 
directly linked to obesity, indicating that the risk for developing metabolic syndrome is 
influenced by other genetic and/or environmental factors. 
Recently, environmental research has shifted from investigating the impact of a 
single chemical on human health to an ‘exposure biology’ approach. By investigating the 
impact of low to moderate chronic exposures in contrast to high acute exposures, this 
approach takes into account the multiple factors that may play a role in the development 




and/or diseases is critical. In this context, environmental exposure to toxicants, such as 
arsenic and cadmium, have been shown to influence various aspects of metabolism (5). 
However, to date, knowledge on the health effects of cadmium and arsenic has resulted 
mostly from adult and/or postnatal exposures. 
While very important, these studies do not take into account that exposure to 
contaminated drinking water is a life-long, multi-generational event. In accordance with 
the ‘Barker hypothesis’, which evolved from the observations that famine-induced low 
birthweight correlated with increased risk of heart disease later in life (6), a number of 
studies have reported that an increased risk of developing adulthood diseases is 
correlated with adverse stimuli in utero that result in permanent physiological and 
metabolic changes (7). In this context, the impact of early life exposures to cadmium or 
arsenic on metabolic syndrome, and the consequences of these exposures in 
conjuncture with high fat diets has not been investigated. 
 
Arsenic 
Arsenic is a naturally occurring, ubiquitous metalloid that continues to be number 
one on the Agency for Toxic Substances and Disease Registry (ATSDR) list of 
hazardous environmental chemicals (8).  Chronic exposure to high concentrations of 
arsenic have been associated with a variety of health problems including skin lesions, 
neurotoxicity, diabetes, hepatotoxicity, and skin, lung, and bladder cancers (9). Inorganic 
arsenic is a natural drinking water contaminant that enters groundwater through the 
erosion of rocks and soils (10). In 2003 it was estimated that nearly 4000 public drinking 
water suppliers in the United States had wells with arsenic levels greater than the 
maximum contaminant level (MCL) of 10 μg/L. Based on census data from 1950-1999, 
this means that over 50 million person-years of exposure to arsenic contaminated 




have artesian water supplies that are unregulated by the Clean Water Act. These 
unregulated water supplies often have high levels of arsenic and are in communities 
where the prevalence of obesity is high; therefore posing potential overlap between 
arsenic exposure and obesity (12). 
The potential overlap between arsenic and obesity was investigated by Tan and 
colleagues (13) in the liver, a major site of arsenic metabolism and a known target of 
arsenic toxicity. Chronic exposure to low concentrations of arsenic was shown to be a 
critical factor that promotes the progression of NAFLD, a feature of metabolic syndrome, 
induced by a high fat diet (13;14). Another example of the association of arsenic with 
metabolic syndrome can been seen with work done by Srivastava et al (15) in which 
prenatal arsenic exposure accelerated the development of atherosclerosis in ApoE -/- 
mice. There is, however, very little information about the interactions between early-life, 
in utero exposures to arsenic and obesity in adults that results in metabolic syndrome.  
 
Cadmium  
Cadmium, ranked number 7 on ATSDRs list of environmental chemical hazards 
(8) is another metal of concern. Cadmium is a ubiquitous, naturally occurring metal that 
is widely used in the production of batteries, pigments, plastics, and galvanized 
products. Anthropogenic sources of cadmium include mining, production of phosphate 
fertilizers, burning of fossil fuels, and incineration of household wastes (16). For non-
smokers, the main source of cadmium exposure is through diet, with more than 80% of 
food-derived cadmium coming from cereals, vegetables, and potatoes (16;17).  Cigarette 
smokers are exposed to high concentrations of cadmium via inhalation because 
cadmium bioaccumulates in the leaves of tobacco plants. Cadmium exposure is 
associated with a number of health effects including renal toxicity, cardiovascular 




Cadmium accumulates in the renal cortex and the liver, with a whole body half-
life between 15 and 30 years (18). Although acute and chronic exposures to cadmium 
are well known models of liver failure in rodent studies, liver-related outcomes as a result 
of cadmium exposure are not well characterized in humans; however there is evidence 
that environmental exposures to cadmium are associated with NAFLD in men, but not 
women (19).  Also unclear is the association between cadmium exposure and obesity, a 
risk factor for NAFLD, as the existing data are contradictory in human studies (20). 
Hence, there is very little information about the interactions between early-life, in utero 
exposures to cadmium and obesity in adults that results in metabolic syndrome.  
The purpose of the current study was to design and characterize a two-hit model 
of multigenerational (F0 and F1) exposures to environmental toxicants, specifically 
cadmium and arsenic, followed by consumption of a high fat diet (F1) in order to begin to 
define the mechanistic interaction of these exposures with obesity, and subsequent 
metabolic syndrome. The results presented here are the initial characterization of the 
hepatic changes observed with the model, as the liver is a major target for arsenic 




MATERIALS AND METHODS 
 
Animals and Exposures 
Six week old male (n=20) and female (n=40) C57BL/6J mice were purchased 
from Jackson Laboratory (Bar Harbor, ME). Mice were housed in a pathogen-free barrier 
facility accredited by the Association for Assessment and Accreditation of Laboratory 
Animal Care, and procedures were approved by the University of Louisville’s Institutional 
Animal Care and Use Committee. Diets were switched from standard laboratory chow to 
AIN-76A purified diet (Envigo TD 160377, Madison, WI) after one week of acclimation in 
the barrier facility. Food and deionized water provided ad libitum. At 10 weeks of age 
mice were started on a drinking water regimen of either deionized water alone (control) 
or toxicant-containing water (100 ppb Arsenic, 500 ppb cadmium, or 5 ppm cadmium).   
Sodium meta(arsenite) (Fluka, Mexico City, Mexico) was used to make a stock 
solution of 1000 ppm arsenic. Stock solution was prepared in deionized water and 100 μl 
aliquots were stored at -80°C. Frozen, aliquoted stock solution was thawed and added to 
deionized water to a final concentration of 100 ppb arsenic and given to mice ad libitum. 
Fresh 100 ppb arsenic containing water was given twice a week to minimize oxidation of 
As(III) to As(V). Water consumption was recorded weekly. The concentration of 100 ppb 
arsenic is within the range of arsenic concentrations seen in both drinking water supplies 
and unregulated artesian wells.  
Cadmium chloride (Alfa Aesar, Tewksbury, MA) was used to make a stock 




100 μl aliquots were stored at -80°C. Once a week frozen, aliquoted stock solution was 
thawed and added to deionized water to a final concentration of either 500 ppb or 5 ppm 
cadmium and given to mice ad libitum. Water consumption was recorded weekly. Based 
on the literature, 5 ppm cadmium is one of the lowest concentrations of cadmium tested 
with results supportive of a metabolic syndrome phenotype; therefore we used 5 ppm 
cadmium as a proof of concept as well as a ten times lower concentration of 500 ppb 
cadmium. 
  At 12 weeks of age mice were placed into breeding triples (1 male to 2 females) 
within each drinking water exposure (Figure 1). Pregnant dams and offspring were 
continuously exposed to the same toxicants as their parents after weaning. At weaning, 
offspring were also fed either a low-fat diet (Envigo TD 160377 - 13% fat, Madison, WI) 
or high-fat diet (Envigo TD 09682 – 42% fat, Madison, MI) (Figure 1). Offspring were 
sacrificed 10 or 24 weeks after weaning. 
Mice were anesthetized with ketamine/xylazine (100/15 mg/kg i.p.) and blood 
was collected from the vena cava prior to sacrifice via exsanguination. Blood samples 
were centrifuged for 1 min at 13,400 rpm and citrated plasma was stored at -80°C for 
further analysis. Organs were harvested from each mouse in the same sequence (Figure 
2). Portions of the pancreas, heart, lung, liver, spleen, kidney, epididymal fat pads, and 
testis/ovary were snap-frozen in liquid nitrogen, fixed in 10% neutral buffered formalin for 
subsequent sectioning and mounting on microscope slides, and used for metals 
analysis.  
 
Histology and Clinical Chemistry 
 Levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
were determined spectrophotometrically using standard kits (Thermo Fisher Scientific, 




mounted on glass slides. Sections were deparaffinized with Citrisolv (Thermo Fisher 
Scientific, Waltham, MA) and rehydrated through graded ethanol washes. Sections were 
then stained with hematoxylin and eosin (H&E) and slides were dehydrated through 
graded ethanol rinses, washed in Citrisolv and mounted with Permount (Thermo Fisher 
Scientific, Waltham, MA). 
  
Metals Analysis 
Each liver sample (20-100mg wet-weight) was digested in 1 mL of 70% 
concentrated trace metal grade nitric acid in an 85°C water bath for 4 h. After digestion, 
34 mL of deionized water was added to each sample. The digested samples were 
filtered using a 100 μm filter. Metal levels were assessed by ICP-MS (Thermofisher 
ICPMS X series II), calculated and presented as ng/g wet tissue. 
  
Statistical Analysis 
 Results are reported as means ± standard error mean (SEM; n = 3-10). ANOVA 
with Bonferroni’s post-hoc test (parametric data) or the Holm-Sidak or Dunn’s Tests (for 
non-parametric data) were used for the determination of statistical significance among 
treatment groups, as appropriate. In vivo: a, p < 0.05 compared to diet; b, p < 0.05 





































Figure 1. Multigenerational exposure to arsenic and cadmium in conjuncture with 
diet. Adult male and female C57BL/6J mice on defined, low-fat diets were exposed to 
control drinking water, or water containing metals(100 ppb As, 500 ppb Cd, or 5 ppm Cd) 
for >2 weeks before being established into breeding pairs.  Pregnant dams and offspring 
were continuously exposed to the same toxicants as their parents after weaning. At 
weaning, offspring were also fed either a low- or high-fat diet (LFD or HFD, respectively) 
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Figure 2. Scheme of organ harvest.  F1 offspring were sacrificed at 10 or 24 weeks 
after being on low fat or high fat diet. On day of sacrifice mice were weighed and 
anesthetized with ketamine/xylazine (100/15 mg/kg i.p.). Blood collection was followed 
by exsanguination and decapitation at which point the brain and eyes were collected and 
the rest of the body was processed in the order seen in the figure starting with the 




 RESULTS  
 
Effect of HFD and toxicant exposure on body weight. 
All animals gained weight as the study progressed and there was no mortality or 
morbidity associated with any group throughout the course of the study. As expected, 
male mice fed HFD gained more weight compared to those fed LFD (Figure 3A and B). 
For example, male mice exposed to control water on HFD gained on average 0.42 
grams more body weight per week compared to LFD fed male mice. This trend was also 
seen in male mice exposed to 100 ppb arsenic, 500 ppb cadmium, and 5 ppm cadmium 
on HFD with an average body weight gain of 0.40, 0.44 and 0.45 grams per week, 
respectively, compared to LFD fed male mice.  
Compared to control, body weight gain was not altered by arsenic exposure in 
male mice fed LFD or HFD. Cadmium exposure did not altered body weight in male mice 
fed LFD. However, HFD in combination with cadmium exposure caused male mice to 
gain less weight compared to control mice at multiple weigh-ins points throughout then 
study. For example, HFD fed male mice exposed to 500 ppb cadmium gained 
significantly less weight compared to controls after 5, 8, 9, and 13 weeks of diet (p = 
0.006, 0.007, 0.031, and 0.017, respectively). In addition, body weights of HFD fed male 
mice at  5, 7, 8, 19, and 20 weeks of diet  were significantly lower than controls (p = 
<0.001, 0.011, 0.007, 0.036, and 0.036, respectively).  
 Similar to the male cohort, female mice fed HFD gained more weight compared 
to those fed LFD (Figure 4A and B); however, to a lesser degree. For example, female 




weight per week compared to LFD female mice, which is approximately 70% less weight 
gain per week compared to males in the same exposure group. Female mice exposed to 
100 ppb arsenic, 500 ppb cadmium, and 5 ppm cadmium on HFD gained 0.29, 0.38, and 
0.27 grams more body weight on average compared to LFD fed female mice, which is 
approximately 27, 14, and 30 percent less weight gain per week compared to males in 
the same exposure group, respectively.  
In contrast to males, arsenic did impact bodyweight in females. Like males, 
arsenic exposure did not alter bodyweight in female mice fed LFD. However, arsenic 
increased weight gain in HFD fed mice compared to control throughout the study, with a 
final average weight gain of 5.8 grams more in arsenic-exposed female mice (Figure 
4B).  Also, in contrast to males, cadmium impacted bodyweight in females. Independent 
of diet, 500 ppb cadmium exposure caused female mice to gain less weight during first 
half of the study. After 5, 7, 8, 9, and 10 weeks of LFD, female mice exposed to 500 ppb 
cadmium gained significantly less weight compared to controls (p = 0.020, 0.017, 
<0.001, 0.043, and 0.048, respectively). LFD fed female mice exposed to 5 ppm 
cadmium also gained less weight compared to controls. However, this lack of weight 
gain was observed throughout the study and not only in the first half as seen in the 500 
ppb cohort. Compared to control, cadmium exposure did not affect body weight gain in 
HFD fed female mice. 
 
Effects of HFD and toxicant exposure on hepatic arsenic concentrations 
In male mice, hepatic arsenic concentrations were not altered by diet or toxicant 
exposure (Figure 5A and B). However, hepatic arsenic concentrations were lower in all 






Figure 3. Effects of diet and toxicant exposure on body weight of F1 male mice.  F1 
generation male mice were treated as described in Material and Methods and body 
weight was monitored weekly. Body weight gain of male mice on a low fat (Panel A) or a 
high fat diet (Panel B), exposed to either control drinking water or toxicant containing 
drinking water is shown. Body weights are shown as means ± SEM for each group (n = 
3-17). # indicates a significant difference (p<0.05) between control and arsenic.  
* indicates a significant difference (p<0.05) between control and 500 ppb cadmium.  








Figure 4. Effects of diet and toxicant exposure on body weight of F1 female mice.  
F1 generation female mice were treated as described in Material and Methods and body 
weight was monitored weekly. Body weight gain of female mice on a low fat (Panel A) or 
a high fat diet (Panel B), exposed to either control drinking water or toxicant containing 
drinking water is shown. Body weights are shown as means ± SEM for each group (n = 
3-20). # indicates a significant difference (p<0.05) between control and arsenic.  
* indicates a significant difference (p<0.05) between control and 500 ppb cadmium.  




concentrations ranging from 50% in the LFD fed, 5 ppm cadmium exposed males, to 
98% in the HFD, 5 ppm cadmium exposed males. This same trend was seen in female 
mice with decreases in hepatic arsenic concentrations ranging from 68% in the LFD fed, 
control water exposed females to 100% in the LFD fed, 500 ppb exposed females. Also, 
as seen in the male cohort, female hepatic arsenic concentrations were not altered by 
diet or arsenic exposure (Figure 6A and B). However, at 10 weeks post-weaning it was 
observed that exposure to 500 ppb cadmium, independent of the diet type (i.e. LFD or 
HFD), significantly increased arsenic concentrations in the liver compared to control (p = 
0.023) (Figure 6A). Interestingly at 24 weeks post-weaning this phenotype was no longer 
seen.  
 
Effects of HFD and toxicant exposure on hepatic cadmium concentrations 
 Hepatic cadmium concentrations in male mice, 10 weeks post-weaning, were 
significantly greater in all three toxicant exposed groups, compared to control and 
independent of diet type (i.e. LFD or HFD) (As: p = 0.005; 500 ppb Cd: p < 0.001 ;5 ppm 
Cd: p < 0.001) (Figure 7A ). As expected there was a concentration-dependent increase 
in hepatic cadmium load with increased cadmium exposure concentration. These trends 
were also seen 24 weeks post-weaning, with one exception. Although hepatic cadmium 
concentrations are  greater after exposure to 500 ppb cadmium, independent of diet, a 
HFD significantly blunted the effect (p = 0.002) (Figure 7B).  
As seen in the male cohort 10 weeks post-weaning, hepatic cadmium 
concentrations in female mice were significantly greater in all three toxicant exposure 
groups, compared to control and independent of diet type (As: p = 0.025; 500 ppb Cd: p 
< 0.001; 5 ppm Cd: p < 0.001) (i.e. LFD or HFD); however toxicant exposed female mice 








Figure 5. Arsenic concentrations in the liver of male F1 mice. F1 generation male 
mice were treated as described in Material and Methods. After 10 weeks (Panel A) or 24 
weeks (Panel B) of being on diet mice were sacrificed and a portion of the liver was 
processed for metals analysis via ICP-MS. Arsenic concentrations (ng/g) are shown as 









Figure 6. Arsenic concentrations in the liver of female F1 mice. F1 generation female 
mice were treated as described in Material and Methods. After 10 weeks (Panel A) or 24 
weeks (Panel B) of being on diet mice were sacrificed and a portion of the liver was 
processed for metals analysis via ICP-MS. Arsenic concentrations (ng/g) are shown as 








Figure 7. Cadmium concentrations in the liver of male F1 mice. F1 generation male 
mice were treated as described in Material and Methods. After 10 weeks (Panel A) or 24 
weeks (Panel B) of being on diet mice were sacrificed and a portion of the liver was 
processed for metals analysis via ICP-MS. Cadmium concentrations (ng/g) are shown as 
means ± SEM for each group (n = 3-8). a, p < 0.05 compared to LFD; b, p < 0.05 





This dimorphic margin increased over time with female hepatic cadmium 
concentrations increasing to between 20 and 85% more cadmium 24 weeks post-
weaning, compared to the corresponding male groups (Figure 8B).  Twenty-four weeks 
post-weaning, female hepatic cadmium concentrations remained significantly greater in 
all toxicant exposure groups, compared to control, as seen in male mice (As: p = 0.013; 
500 ppb Cd: p < 0.001; 5 ppm Cd: p < 0.001). However, not seen in males, HFD fed 
female mice exposed to 5 ppm cadmium had significantly greater hepatic cadmium 
concentrations compared to LFD females in the same exposure group (p < 0.001).   
 
Effect of HFD and toxicant exposure on liver weight 
In male mice, at 10 weeks post-weaning, there was no effect of HFD, arsenic or 
500 ppb cadmium exposure on liver-to-body weight ratios (Figure 9A). Independent of 
diet, exposure to 5 ppm cadmium significantly increased liver size in male mice (p = 
0.003). By 24 weeks post weening, this phenotype was gone; however HFD significantly 
increased liver size compared to LFD in all exposure groups (As: p = <0.001; 500 ppb 
Cd: p < 0.001; 5 ppm Cd: p < 0.001) (Figure 9B). For example, there was a 2-fold 
increase in the liver size of HFD fed mice exposed to control and arsenic containing 
water compared to LFD.  In female mice, at both 10 and 24 weeks post weening, neither 
HFD nor toxicant exposure altered liver-to-body weight ratios (Figure 10A and B).  
 
Effects of HFD and toxicant exposure on plasma AST: index of liver damage 
 
 As expected by the observation of unchanged liver size, 10 weeks of HFD 
feeding did not affect AST levels in male or female mice (Figure 11A and 12A). In male 
mice, after 24 weeks of HFD feeding, although a trend towards greater AST levels was 









Figure 8. Cadmium concentrations in the liver of female F1 mice. F1 generation 
female mice were treated as described in Material and Methods. After 10 weeks (Panel 
A) or 24 weeks (Panel B) of being on diet mice were sacrificed were sacrificed and a 
portion of the liver was processed for metals analysis via ICP-MS. Cadmium 
concentrations (ng/g) are shown as means ± SEM for each group (n = 1-10). a, p < 0.05 








Figure 9. High fat diet caused hepatomegaly in male mice independent of toxicant 
exposure.  F1 generation male mice were treated as described in Material and Methods. 
After 10 weeks (Panel A) or 24 weeks (Panel B) of being on diet mice were sacrificed 
and body and liver weights were recorded. Liver-to-body weight ratios (LW/BW%) are 
shown as means ± SEM for each group (n = 3-8). a, p < 0.05 compared to LFD; b, p < 







Figure 10. Neither diet nor toxicant exposure significantly alters liver-to-body 
weight ratios in female mice. F1 generation female mice were treated as described in 
Material and Methods. After 10 weeks (Panel A) or 24 weeks (Panel B) of being on diet 
mice were sacrificed and body and liver weights were recorded. Liver-to-body weight 
ratios (LW/BW%) are shown as means ± SEM for each group (n = 4-10). There were no 





in only the cadmium exposed mice (500 ppb Cd: p = 0.007; 5 ppm Cd: p = 0.030) 
(Figure 11B).  Neither HFD nor toxicant exposure altered AST levels in female mice after 
24 weeks, which is reflective of the unchanged liver-to-body weight ratios (Figure 12B).  
 
Effect of HFD and toxicant exposure on liver health: histology  
 Neither diet nor to toxicant exposure altered liver morphology or lipid 
accumulation in male or female mice at 10 weeks post weening, as expected by 
unaltered liver size and AST activity (Figure 13A and 14A). However, by 24 weeks post-
weaning liver health was altered by both diet and metal exposure. In LFD fed male mice, 
arsenic exposure increased liver inflammation while exposure to both concentration of 
cadmium caused structural changes in the liver (Figure 13B, upper panels). HFD feeding 
increased lipid accumulation in the liver compared to LFD, causing both microvesicular 
and macrovesicular steatosis (Figure 13B, lower left panel). This pathology was 
enhanced by low dose Cd (500 ppb) and to a greater extent by high dose Cd (5 ppm), as 
indicated by larger, more numerous lipid droplets as well as necroinflammatory foci 
(Figure 13B, lower left panels). Arsenic exposure in combination with HFD increased 
microvesicular steatosis only.  
In females, low dose Cd (500 ppb) exposure did not alter liver histology in mice 
fed LFD; however independent of diet, arsenic caused simple steatosis and high dose 
Cd (5 ppm) caused structural changes in the liver (Figure 14B, upper panels). HFD 
caused moderate alterations in liver histology in both control and Cd treated mice, as 
indicated by marginal increases in lipid accumulation and structural changes (Figure 14 
B, lower panels). HFD feeding enhanced the arsenic-induced steatosis seen with LFD 
feeding. Overall, all toxicant exposures tended to exacerbate the effect of HFD on liver 







Figure 11. Plasma aspartate aminotransferase activity (AST) in male mice. 
F1 generation male mice were treated as described in Material and Methods. After 10 
weeks (Panel A) or 24 weeks (Panel B) of being on diet mice were sacrificed and 
plasma aspartate aminotransferase (AST) activity was measured as a marker of liver 
injury. AST activity (IU/L) is shown as means ± SEM for each group (n = 3-8). a, p < 0.05 








Figure 12. Plasma aspartate aminotransferase activity (AST) in female mice.   
F1 generation female mice were treated as described in Material and Methods. After 10 
weeks (Panel A) or 24 weeks (Panel B) of being on diet mice were sacrificed and 
plasma aspartate aminotransferase (AST) activity was measured as a marker of liver 










Figure 13. Effect of arsenic and cadmium on high fat diet induced liver injury in 
male mice. F1 generation male mice were treated as described in Material and Methods. 
Panel A shows representative photomicrographs of hematoxylin & eosin staining (H&E, 
200x) of the liver tissue of male mice after 10 weeks of being on either LFD or HFD. 
Panel B shows representative photomicrographs of hematoxylin & eosin staining (H&E, 










Figure 14. Effect of arsenic and cadmium in conjuncture with high fat diet on liver 
injury in female mice. F1 generation female mice were treated as described in Material 
and Methods. Panel A shows representative photomicrographs of hematoxylin & eosin 
staining (H&E, 200x) of the liver tissue of female mice after 10 weeks of being on either 
LFD or HFD. Panel B shows representative photomicrographs of hematoxylin & eosin 
staining (H&E, 200x) of the liver tissue of female mice after 24 weeks of being on either 






Obesity, a major public health concern affecting over 312 million people 
worldwide, is a primary risk factor for the development of metabolic syndrome; however, 
only 65% of obese males and 56% of obese females meet metabolic syndrome criteria 
(23), indicating the influence of other risk factors such as genetics and/or environmental 
exposures. Previous studies have correlated environmental exposures to arsenic and 
cadmium with the development of several metabolic disease pathologies including type 
2 diabetes, hypertension, and atherosclerosis (3;5;24). These studies, however, do not 
take into account that such environmental exposures can be life-long and 
multigenerational. Therefore the purpose of the current study was to establish an in vivo 
model to look at the effects of early life exposure to chronic, low dose arsenic or 
cadmium on the development of metabolic syndrome pathologies associated with high 
fat diets. 
 The results presented here are the initial hepatic changes associated with the 
model. We choose the liver as the initial target organ, because as stated in the 
introduction, the liver is major site for arsenic metabolism and toxicity (21) and a major 
target organ of cadmium toxicity and accumulation (22). Importantly, endpoints were 
looked at in both male and female mice exposed in-utero and postnatally to arsenic or 
cadmium as there are significant difference in obesity and lipid metabolism between the 
genders (25). Initially these endpoints were to be examined after 10 weeks of diet, post-
weaning; however the hepatic changes expected based on the literature were not 




Previously it has been shown that male mice fed a high fat, “Western Diet” (42% 
calories) for 10 weeks gained more weight and had enlarged livers with significantly 
more lipid accumulation compared to LFD fed mice (13). These results are consistent 
with other studies using this diet (26;27); however with our model, although we did see 
increases in average weight gain, we did not see hepatomegaly or lipid accumulation in 
the liver after 10 weeks of HFD feeding (Figures 3, 9, and 13).  
It is important to point out that in the above contradictory studies mice were 
started on HFD between 6-8 weeks of age, whereas in our model, mice were started on 
HFD at weaning, or 3 weeks of age. Although a difference of 3-5 weeks may not seem 
like a long time, in “mouse days” it can be the difference between puberty and 
adulthood. A 3, 6, and 8-10 week old mouse is comparable to a 6 month old, 11.5 year 
old, and 20 year old human, respectively (28). Age-induced metabolic changes may 
account for these discrepancies (29).  
By 24 weeks of being fed HFD we did indeed observe hepatic changes in male 
mice consistent with the previously reported HFD-induced fatty liver disease models (30) 
including hepatomegaly and micro-and macrovesicular steatosis (Figures 9 and 13). 
Although female mice did gain weight with HFD feeding (Figure 4), it was at a slower 
rate than male mice, and interestingly, HFD did not alter liver-to-body weight ratios 
(Figure 10) and only induced moderate lipid accumulation (Figure 14). This is not 
surprising as it is well established that there are sex differences in the susceptibility to 
various disease (25), and more specifically it has been shown that female mice are 
actually protected against HFD-induced metabolic syndrome (31).  
The effects of two possible environmental obesogens, arsenic and cadmium, on 
HFD-induced liver damage was examined in both males and females. The influence of 
these toxicants on HFD-induced pathologies is poorly understood; however both arsenic 






The “environmental obesogen” hypothesis, suggests that the risk for obesity may 
increase as a result of environmental exposures (32). Arsenic is one such environmental 
pollutant that has been recognized as a risk factor for the development of health 
conditions associated with obesity such as type 2 diabetes, hypertension, and non-
alcoholic fatty liver disease (1). Furthermore, obese individuals have been shown to 
metabolize arsenicals less efficiently than normal-weighted individuals; therefore, 
suggesting a link between obesity and susceptibility to arsenic toxicity (33). However in 
the literature there are substantial differences in the duration of treatment and the doses 
of arsenic used (34); therefore there is uncertainty underlining the mechanisms of 
arsenic toxicity and its role as an obesogen.  
The contradictory results in the literature due to arsenic dose is best exemplified 
by hepatic arsenic concentrations. In our study we saw that neither HFD nor exposure to 
low level, 100 ppb arsenic resulted in arsenic accumulation in the liver (Figure 5 and 6). 
To the contrary, it has been shown that arsenic does accumulate in the liver in a 
concentration-dependent manner; however, the arsenic exposures were 250 to 500 
times greater in the contradictory study compared the current study (35). Interestingly, 
Markowski et al (36) investigated the effects of multiple concentrations of arsenic and 
found that the offspring of female mice exposed to increasing concentrations of arsenic 
in drinking water, up to 20 ppm, had similar concentrations of arsenic in their liver 
compared to controls; however exposure to concentrations < 40 ppm resulted in hepatic 
accumulation of arsenic (36). In human studies, hepatic arsenic levels did not correlate 
with either the degree of fibrosis in the liver or the amount of arsenic in the drinking 
water (21). Although arsenic may not accumulate in the liver after exposure to 




One study showed that the offspring of female mice exposed to 100 ppb arsenic 
during pregnancy developed NAFLD and were at higher risk for developing metabolic 
syndrome (37). This study specifically looked at 36 week old male and female offspring 
of dams exposed to 100 ppb arsenic from embryonic day (ED) 6 until birth, and although 
a trend towards larger body weights was observed, there was no statistical difference 
compared to controls. Interestingly, although arsenic exposure did not lead to weight 
gain in either male or female mice, both prominent micro- and macrovesicular steatosis 
was observed (37). In the current study, arsenic exposure did not affect weight gain in 
male or female mice (Figures 3 and 4), which is also supported by other studies (13;15). 
Also, although prominent micro- and macrovesicular steatosis was not observed hepatic 
inflammation in male mice and simple steatosis in  female mice was observed (Figures 1 
and 14). The differences in histology may be an artifact of the shorter length of our 
study. 
Another study in CD-1 mice showed that in utero exposure to low level arsenic 
(10 ppb) during the second half of gestation led to obesity in female offspring (38). 
Although this study does not consider the impact of a high fat diet, it does suggest that 
there are mechanism by which arsenic alone can increase the risk of obesity in female 
mice. In the model used in the current study, arsenic alone did not alter weight gain, but 
may have caused pathologically inert biochemical and/or physiological changes in utero 
that altered the ability of the offspring to metabolize a high fat diet.  
Interestingly, in that the current study female mice fed HFD, exposed to arsenic 
gained more weight on average compared to control (Figure 4B), suggesting that arsenic 
exposure may enhance the effects of HFD-induced weight gain in female mice. Although 
arsenic exposure has not been directly linked to increases in fat mass per se, arsenic 




metabolism (32;39), that when challenged with a “second-hit”, such as a high fat diet, 
may enhance the risk of developing obesity.  
This ‘second hit’ hypothesis has been well demonstrated in models of fatty liver 
disease (40). For example, subhepatotoxic exposure to arsenic has been shown to 
enhance HFD-induced liver damage (13). In the current study, HFD-induced 
hepatomegaly was unaltered by arsenic exposure in male mice (Figure 9); however, in 
contradiction to Tan et al (13) arsenic exposure enhanced microvesicular steatosis. One 
possible explanation for the contradiction is the utilization of different exposure models. 
Although both studies exposed mice to 100 ppb arsenic in drinking water, mice in our 
study were exposed in utero and postnatally (Figure 1), whereas in the Tan et al (13) 
study mice were only exposed postnatally. This explanation is supported by a study that 
looked at the effects of in utero (IU), postnatal (PN), and continual exposures (in utero + 
postnatal) (IU+) to 100 ppb arsenic combined with a high fat diet (41). It was concluded 
that NAFLD was present in both groups exposed to arsenic in utero, and the severity of 
the pathology was greater when exposure to arsenic was continued postnatally.  
Taken together these initial findings suggest that “whole life” arsenic exposure 
enhances liver injury caused by HFD in male mice and to lesser degree in female mice, 
although arsenic exposure exacerbated HFD-induced weight gain in females only, 
suggesting sex-related differences in the mechanism of arsenic-induced hepatotoxicity 
and possibly the development of metabolic syndrome.  
 
Cadmium 
Metabolic syndrome has been associated with a number of toxic metals and 
metalloids, including mercury (42), lead (43), and arsenic (24). However, the association 
and underlying mechanism of cadmium exposure with metabolic syndrome pathologies, 




exposure in obesity is contradictory with studies showing negative, positive, and no 
correlations between exposure and weight gain. In animal studies, such as ours, 
cadmium exposure did not cause weight gain in male or female mice (Figures 3 and 4) 
(44; 45), whereas another study showed that female rats exposed to cadmium had 
significantly lower body weights compared to control (46). As seen in the arsenic 
literature, these discrepancies may be due, in part, to differences in route of exposure 
and exposure levels (20).  
It is well known that cadmium accumulates in the liver due to high metallothionein 
(MT) levels, a metal binding protein with a high affinity for cadmium (47), and has a 
whole body half-life between 15 and 30 years (18). Therefore, it is not surprising that 
cadmium exposure resulted in a concentration-dependent increase in hepatic cadmium 
in both male and female mice at 10 and 24 weeks post-weaning (Figures 7 and 8). 
Female mice accumulated more cadmium in their livers than male mice, consistent with 
the literature that cadmium retention is generally higher in women than men (48; 49).  
For more than a half a century it has been thought that women are more affected 
by cadmium than men in part due to greater body burden and in part due to cadmium-
induced Itai-itai disease, which affects the kidney and bones and is mainly seen in 
women (49-52). We found that although cadmium concentrations were greater in the 
livers of female mice, histology showed alterations in the arrangement of normal 
sinusoidal architecture at both low (500 ppb) and high (5 ppm) cadmium exposures in 
male mice (Figure 13), but to a lesser extent in cadmium exposed females (Figure 14). 
Loss of normal parenchymal tissue architecture in the liver has been associated with 
cadmium exposure in male rodents, whereas studies on liver architecture in cadmium-
exposed females is lacking.    
Interestingly, in humans, cadmium-induced liver disease is more prevalent and 




accumulates to a greater extent in the livers of females (52), which is consistent with the 
findings of this study. Exposure to environmental cadmium has been associated with a 
higher risk of hepatic necroinflammation, NAFLD, and NASH (non-alcoholic 
steatohepatitis) in males whereas in females exposure was associated with hepatic 
necroinflammation only, and to a lesser degree than that seen in the males (19). 
Although it is clear that chronic cadmium exposure induces hepatotoxicity, the 
mechanism(s) are not fully understood.  
Hepatic gene expression profiling of adult mice that were exposed to low dose 
cadmium in utero and continuously throughout life showed enhanced expression of 
genes involved in fatty acid and lipid metabolism in male, but not female mice (54). 
Cadmium has also been shown to alter lipid and carbohydrate metabolism in adipocytes 
resulting in impaired adipogenesis. This alteration in adipose tissue physiology may 
induce an obesity-associated metabolic profile that promotes pathologies associated 
with metabolic syndrome, such as insulin resistance and type 2 diabetes (55).  
Due to the effects of cadmium on metabolic processes in male mice it is not 
surprising that in this study HFD-induced steatosis in male mice was exacerbated by 
cadmium exposure in a concentration-dependent manner (Figure 13). Observations that 
cadmium only caused moderate structural change in the liver of HFD-fed female mice 
(Figure 14) is supported by research that shows cadmium does not enhance expression 
of genes involved in fatty acid and lipid metabolism (54). Cadmium exposure potentiate 
other pathologies, such as LPS-induced inflammation linked to metabolic syndrome (56); 
therefore it reasonable to suggest, based on the findings from the current study, that 





SUMMARY AND CONCLUSIONS 
 
STRENGTHS OF THIS WORK 
The purpose of this work was to establish an in vivo, two-hit model to study the 
effects of whole life exposure (preconception to time of sacrifice) of arsenic or cadmium 
on the development and progression of high fat diet-induced metabolic syndrome 
pathologies. To our knowledge this is the first study with this exposure paradigm for 
either toxicant. As metabolic syndrome is a group of diseases affecting multiple organs 
in the body, it is important to point out that all of the work was performed in the whole 
animal. Tissue samples from over 10 organs were harvested from each animal, allowing 
for various endpoints to be examined both within and between (cross-talk) multiple 
organs as well as creating the possibility for collaboration. Additionally, the exposures 
were in both sexes which is important considering the National Institute of Health 
requirement for accounting for sex as a biological variable. Indeed, the initial 
characterization of the hepatic changes associated with this model revealed sexual 
dimorphism as well as established that exposure to arsenic and cadmium exacerbate 
HFD-induced liver disease, a pathology associated with metabolic syndrome. 
 
CAVEATS AND WEAKNESSES 
One of the weaknesses of this study is that the model does not account for in 
utero exposure alone or postnatal exposure alone, both of which are windows of 
susceptibility that may be differently impacted by toxicant exposure. Assessment of the 




in combination may better elucidate the molecular processes involved in development of 
metabolic syndrome pathologies later in life.  
  After 10 weeks of diet the hepatic changes that were expected were not 
observed; therefore the study was carried out to 24 weeks. Due to this unexpected, but 
necessary extension of the study there were fewer animals in each exposure group at 
the 24 week time point, impacting statistical power.  This extension also resulted in the 




This study has laid the foundation for studying the mechanism by which an early 
life exposure to cadmium or arsenic exacerbates disease phenotypes associated HFD- 
induced obesity, and subsequent metabolic syndrome. Numerous collaborations have 
resulted from this study and future work will build on our initial findings and examine 
other target organs of metabolic syndrome. For example, “omics” approaches have been 
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